CARTILAGE THICKNESS MODIFICATION WITH SPRIFERMIN IN KNEE OSTEOARTHRITIS PATIENTS TRANSLATES INTO SYMPTOMATIC IMPROVEMENT OVER PLACEBO IN PATIENTS AT RISK OF FURTHER STRUCTURAL AND SYMPTOMATIC PROGRESSION: POST-HOC ANALYSIS OF THE PHASE II FORWARD TRIAL

H Guhring, J Kraines, F Moreau, B Daelken, C Ladel, Wolfgang Wirth, PG Conaghan, Felix Eckstein, M Hochberg

Research output: Contribution to journalpublished Abstract (Journal)peer-review

10 Citations (Web of Science)
Original languageEnglish
Pages (from-to)70-71
JournalANNALS OF THE RHEUMATIC DISEASES
Volume78
DOIs
Publication statusPublished - 2019
EventAnnual European Congress of Rheumatology (EULAR) - Madrid, SPAIN
Duration: 12 Jun 201915 Jun 2019

Cite this